Hypertrophic cardiomyopathy (HCM) is considered a hereditary autosomal dominant condition, but genetic testing is positive in only half of patients. In patients with negative genetic tests, the ...

Please provide your email address to receive an email when new articles are posted on . Rare and common genetic variants contribute substantially to susceptibility to hypertrophic cardiomyopathy in ...

Hypertrophic cardiomyopathy (HCM) is a genetic heart disease that causes thickening of the walls of the heart’s left ventricle. This can make it more difficult for the heart to pump blood throughout ...

The FDA has approved the drug Camzyos to treat obstructive hypertrophic cardiomyopathy (HCM). A second drug is currently under review. Other medications and lifestyle strategies can also help manage ...